- Status:
- Red
- Decision Date:
- September 2022
Comments
RED:
- Treatment
of chronic hepatitis delta virus (HDV) infection in plasma (or serum) HDV-RNA
positive adults with compensated liver disease.
- NICE TA896 - Bulevirtide for treating chronic hepatitis D. (Decision date - July 2023)
NHS England commissioned drug. To be used in line with NHSE commissioning intentions.
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again
